The Items Predicting Non-Remission after 6 Months of Treatment of Patients with Generalized Anxiety Disorder Covered the Eysenck Neuroticism Components of Anxiety, Interpersonal Sensitivity and Depression

Bech, Per; Rickels, Karl

doi:10.1159/000444454

Cited by 8 publications

(5 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In another study using the EPI neuroticism scale, an attempt was made to identify the items which predicted non-remission after 6 months of treatment in patients with generalized anxiety disorder (Bech and Rickels 2016). In this study, a score of 8 or more on the Hamilton Anxiety Scale was the criterion of non-remission.…”

Section: The Predictive Validity Of the Eysenck Neuroticism Scalementioning

confidence: 97%

“…Thus, most of Eysenck's factor analytic studies have been carried out on nonclinical populations, typically college students. Using a clinical population of patients with different types of depression, the EPQ neuroticism scale was evaluated, using an experienced psychiatrist with competence in neurotic disorders as index of clinical validity (Bech et al 1986). When compared to other personality questionnaires, the EPQ neuroticism scale was the only one to correspond significantly with the experienced psychiatrist's assessment.…”

Section: Psychometric Propertiesmentioning

confidence: 99%

See 1 more Smart Citation

Neuroticism (Eysenck’s Theory)

Bech¹

2016

Encyclopedia of Personality and Individual Differences

Self Cite

View full text Add to dashboard Cite

The Eysenck personality theory is based on the four classic temperaments (melancholic, choleric, phlegmatic, and sanguine) which Wilhelm Wundt integrated in the two dimensions of neuroticism and extraversion. Neuroticism covers the melancholic and choleric temperaments as a personality trait, i.e., a disposition-oriented tendency to react too emotionally in certain situations. Neuroticism, or emotionality, is the most distinct of Eysenck's personality traits. It was also historically the first trait he defined. Thus, the Maudsley Medical Questionnaire (MMQ) was constructed to measure the personality trait of neuroticism. The MMQ contained 40 items. To cover both neuroticism and extraversion, the Maudsley Personality Inventory (MPI) was developed in 1956. A short version of the MPI containing six neuroticism items was published by Eysenck in 1958. The Eysenck Personality Inventory (EPI) was developed by Eysenck and Eysenck in 1959. In this version, a Lie subscale was included to evaluate the respondent's test-taking behavior, i.e., the extent to which the individual was "faking good." The Eysenck Personality Questionnaire (EPQ) (Eysenck and Eysenck 1975) should be considered as the final measure of the Eysenck personality traits of neuroticism, extraversion (Bech 2017a), or psychoticism (Bech 2017b), still including the Lie subscale with 21 items. However, Eysenck et al. (1985) ultimately published a revised version (EPQ-R) in which one single extra item concerning the neuroticism scale was added to the 1975 version, but this item is of doubtful validity and is not included in the short-scale EPQ-R (Table 1). The Lie subscale in the EPQ-R was the unchanged 21-item version.

show abstract

Section: The Predictive Validity Of the Eysenck Neuroticism Scalementioning

confidence: 97%

Section: Psychometric Propertiesmentioning

confidence: 99%

Neuroticism (Eysenck’s Theory)

Bech¹

2016

Encyclopedia of Personality and Individual Differences

Self Cite

View full text Add to dashboard Cite

show abstract

“…Further, high sensitivity is required for detecting residual symptomatology, which was found to characterize the majority of patients who were judged to be remitted according to DSM criteria and no longer in need of active treatment [39]. Excessive reliance on symptoms that are part of diagnostic criteria of mental disorders (e.g., major depressive disorder, generalized anxiety disorder) has impoverished clinical assessment in psychopharmacology and does not reflect the broad spectrum of variables that affect clinical presentations: subclinical distress [39], such as demoralization and irritable mood [40], psychological well-being and euthymia [41,42,43], mental pain [44,45,46,47], social adjustment [48], and neuroticism [49,50]. …”

Section: Areas Of Applicationmentioning

confidence: 99%

Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks

Fava

Tomba

Bech

2017

Psychother Psychosom

Self Cite

View full text Add to dashboard Cite

The aim of this critical review was to outline emerging trends and perspectives of clinical pharmacopsychology, an area of clinical psychology that is concerned with the psychological effects of medications. The historical development of clinical pharmacopsychology is outlined, with discussion of its most representative expressions and reference to current challenges of clinical research, with particular reference to clinimetrics. The domains of clinical pharmacopsychology encompass the clinical benefits of psychotropic drugs, the characteristics that predict responsiveness to treatment, the vulnerabilities induced by treatment (side effects, behavioral toxicity, iatrogenic comorbidity), and the interactions between drug treatment and psychological variables. Its aim is to provide a comprehensive assessment of the clinical important changes that are concerned with (a) wanted and expected treatment effects, (b) treatment-induced unwanted side effects, and (c) the patient's own personal experience of a change in terms of well-being and/or quality of life. Clinical pharmacopsychology offers a unifying framework for the understanding of clinical phenomena in medical and psychiatric settings. Research in this area deserves high priority.

show abstract

“…Sirri et al [19] have, among the patient-related variables within illness behavior, identified neuroticism as significantly associated with low adherence to medical treatment. Within mental disorders the Eysenck Neuroticism Scale has been shown to have predictive validity both in studies with anxiety disorder [20] and in studies with depression [21]. The type A behavior considered to be a personality trait associated with medical conditions [22] should be regarded as part of the Eysenck extraversion dimension [23,24].…”

Section: Discriminatory Versus Predictive Validitymentioning

confidence: 99%